hat
Te gen anpil randomized etid kontwole vle di yo mennen ankèt sou efè a pèdi pwa nan sibutramine. Nan yon sèl etid, volontè 1047 obèz yo te pran diferan dòz plasebo oswa sibutramin pou yon dire de sis mwa. Pèdi pwa debaz la ak plasebo te pousantaj 2.7, pousan 7.4 ak milimèt / jou, pousantaj 25 miligram / jou, ak pousan 6.1 ak miligram / jou.
eng
There have been many randomized controlled studies meant to investigate the weight loss effect of sibutramine. In one study, 1047 obese volunteers undertook different doses of placebo or sibutramine for a duration of six months. The baseline weight loss with placebo was 2.7 percent, 7.4 percent with 25 milligram/day, 6.1 percent with 10 milligram/day, and 3.9 percent with 5 milligram/day.